David A. Holbrook

Cancer Research UK provides cancer research services. It supports and undertakes research on the biology and causes of cancer and develops anti-cancer drugs. The firm also provides general information about cancer and types of treatments and funds projects that help patients cope with the side effects of cancer and its treatment. Its institute also operates an online portal CancerHelp UK that provides patient information. The company was founded in 2001 and is headquartered in London, the United Kingdom.

Cumulus Neuroscience Ltd. is a company based in Belfast, Ireland. The Irish company achieves this through the use of machine learning analytics and the world's largest database of annotated, longitudinal, neurofunctional data. Cumulus Neuroscience aims to generate the data and insights necessary to accelerate the diagnosis and management of central nervous system disorders. The company's AI-based, multi-domain digital biomarker platform enables better and faster decision-making in neurology and neuropsychiatry clinical trials and patient care. Cumulus Neuroscience Ltd. is supported by specialized investors and has a world-class scientific and technical advisory board. The company, founded by Ronan Cunningham, Ruth McKernan, Brian Murphy, Sigurdur Sævarsson, and Urs Markus Ernst Streidl, is focused on simplifying and improving the robustness of neuroscience clinical trials. Aman Bhatti has been the CEO of the company since 2022.

Surgery Hero Ltd. was founded in 2020 and is based in Leeds, UK. The British company aims to improve employee lives and reduce healthcare spend by combining expert human care, individually-tailored content, and cutting-edge technology to empower people to take control of their health and conquer their surgery. The company works with the NHS, supporting trusts, CCGs, and ICSs across the UK. The company provides peer-reviewed clinical studies, ongoing research, and insights into digital health, preventive healthcare, and perioperative medicine from the Surgery Hero team and other experts.

UCL Business Plc operates as a technology transfer company. The company was founded in 2002 and is headquartered in London, the United Kingdom.

Part of Mallinckrodt Plc, Mallinckrodt Pharmaceuticals Ltd. is a British pharmaceutical company that manufactures pharmaceutical products. The company is based in Staines Upon Thames, UK and was founded in 2015.

Merck Sharp & Dohme Corp. engages in the research, development, and distribution of vaccines, prescription drugs, and animal health products. The company is headquartered in Whitehouse Station, NJ.

A.T. Kearney Ltd. engages in the provision of business management consulting services. It offers digital transformation, operations, procurement, marketing and sales services, The company was founded in 1926 and is headquartered in London, the United Kingdom.

Bupa Ltd. is a leading healthcare specialist that offers a wide range of care services, including nursing homes and elderly care for conditions such as dementia. The private company is based in London, UK. The British company's purpose is to help people live longer, healthier, and happier lives. Bupa provides private medical insurance, health clinics, and care homes, and they have a care home finder tool to make it easy for individuals to find suitable care options. Bupa was founded by Alexandra Lemacon.

Cancer Research Technology Ltd. develops cancer therapeutics, vaccines, and diagnostics. The firm also provides project development, commercialization, drug discovery, clinical development, imaging, and funding services. The company was founded in 2002 and is headquartered in London, the United Kingdom.

Advent Venture Partners LLP (AVP) is a private equity/venture capital firm founded in 1981 by David James Scott Cooksey. The firm is headquartered in London, United Kingdom.

Exvastat Ltd. operates as pharmaceutical company. The firm develops treatment for acute respiratory distress syndrome (ARDS) based on a repurposed drug which is marketed worldwide for other indications. The company was founded by David Cavalla , Charlotte Summers and Andrew McElroy in 2016 and is headquartered in Cambridge, the United Kingdom.

Montis Biosciences BV engages in the development of immune-oncology therapeutics targetting the intersection between vascular dysfunction and immune suppression to treat solid tumors. It offers target screening and assay platform to discover novel targets modulating interactions between tumor endothelial cells and perivascular macrophages. The company was founded by Peter Carmeliet and Massimiliano Mazzone and is headquartered in Meise, Belgium.

Alsa Management Services Ltd (ALSA Ventures) is a venture capital firm founded in 2018. The firm is headquartered in London, United Kingdom.

Pheno Therapeutics Ltd. operates as a biotechnology company. The firm develops remyelinating therapies for the unmet need for a neuroprotective therapy for multiple sclerosis. The company was founded on October 31, 2018 and is headquartered in Edinburgh, the United Kingdom.

Maxion Therapeutics is a British company that specializes in creating first-in-class and protein therapeutics for treating previously untreatable ion channel- and GPCR-driven diseases. The company was founded by John McCafferty, Aneesh Karatt-Vellatt, and is based in London, UK. The company achieves this through their revolutionary KnotBody® technology. John McCafferty has been the CEO since incorporation.

The BioIndustry Association is a UK-based organization that represents the life sciences and biotech industry. The British company's mission is to facilitate and connect the ecosystem to help businesses start, grow, and deliver world-changing innovation. The non-profit company was founded by Cormac G. Kilty and Simon Geoffrey Best, and Steve Bates has been the CEO of the company since 2012.

Cambridge Innovation Capital Ltd (Cambridge Innovation Capital) is a venture capital firm founded in 2013. The firm is headquartered in Cambridge, United Kingdom.

Ducentis Biotherapeutics Ltd. develops novel therapies for inflammation and autoimmune disease. The company was founded by Rebecca Ashfield, David Blackbourn and Philip Huxley in March 2015 and is headquartered in Witney, the United Kingdom.

Avvinity Therapeutics Ltd. develops novel immuno-therapeutics. The British company was founded in 2016 by Mike Westby, Jonathan David Moore. The CEO is Nick Staples.

RQ Biotechnology Ltd. is a British company that provides biotechnology research and development services. The company was founded in 2021 by Michael Westby, Jane Osbourn, Paul Kellam. Hugo Rupert Alexander Fry has been the CEO of the company since 2022.

DJS Antibodies Ltd. designs and discovers novel therapeutic monoclonal antibodies against G-protein-coupled receptors. The firm conducts discovery against three targets in the fields of oncology, fibrosis and vascular disease. The company was founded by David Colin Conway Llewellyn and Joseph James Illingworth and is headquartered in Bicester, the United Kingdom.

Stevenage Bioscience Catalyst offers access to equipment and facilities that would otherwise be beyond the reach of small or medium-sized companies. The company is headquartered in Stevenage, the United Kingdom.